Post-acquisition integration Fibroblast was acquired by Cerner Corporation in October 2020, indicating potential alignment opportunities with Cerner’s healthcare IT ecosystem and patient referral workflows.

Referral optimization niche Fibroblast specializes in automating the end-to-end referral process to reduce patient leakage and boost revenue, presenting a target for cross-sell to healthcare providers seeking ROI in referral management.

Technical stack fit With a stack including Salesforce, React, C#, and MySQL, there is synergy for selling to mid-market healthcare IT teams already invested in these technologies or seeking seamless integration with Cerner systems.

Financial and scale signals Current revenue is minimal ($0–$1M) and employee count is small (2–10), indicating a growth opportunity through larger Cerner-aligned health systems or accelerator programs within Cerner’s network.

Competitive positioning Operating in the healthcare IT services space with a focus on referral workflows places Fibroblast in a competitive set alongside large EHR and care coordination vendors, suggesting a need to highlight measurable ROI and risk reduction to win deals within Cerner’s ecosystem.